Reação de hipersensibilidade atípica à injeção de toxina botulínica
DOI:
https://doi.org/10.48208/HeadacheMed.2023.21Palavras-chave:
Botox, Anafilaxia, Efeitos colaterais e reações adversas relacionados a medicamentos, Dor de cabeça crônicaResumo
A injeção de toxina botulínica tipo A (BTA), comercializada como BOTOX, é comumente usada como tratamento para uma variedade de indicações clínicas e é amplamente considerada segura, eficaz e amplamente desprovida de efeitos colaterais graves. As reações anafiláticas ao BTA são tipicamente inéditas na literatura científica. BOTOX é aprovado pela Food and Drug Administration para o tratamento da distonia cervical e profilaxia para enxaquecas crônicas. Este relato de caso documenta um caso único de reação alérgica ao BTA em uma mulher de 29 anos com dor de cabeça cervicogênica e distonia cervical que relatou rubor imediato, tontura e náusea após receber injeções de BTA.
Downloads
Referências
Sjaastad O, Saunte C, Hovdahl H, Breivik H and Grønbâk E. “Cervicogenic” Headache. An Hypothesis. Cephalalgia 2016; 3(4): 249-256 Doi:10.1046/j.1468-2982.1983.0304249.x DOI: https://doi.org/10.1046/j.1468-2982.1983.0304249.x
Moore C, Diaz D and Kane A. Physical Therapy Management of Adults with Mild Traumatic Brain Injury. Seminars in Speech and Language 2019; 40(01): 036-047 Doi:10.1055/s-0038-1676652 DOI: https://doi.org/10.1055/s-0038-1676652
Wu B, Yue L, Sun F, Gao S, Liang B and Tao T. The Feasibility and Efficacy of Ultrasound-Guided C2 Nerve Root Coblation for Cervicogenic Headache. Pain Medicine 2019; 20(6): 1219-1226 Doi:10.1093/pm/pny227 DOI: https://doi.org/10.1093/pm/pny227
Moye LS, Tipton AF, Dripps I, Sheets Z, Crombie A, Violin JD and Pradhan AA. Delta opioid receptor agonists are effective for multiple types of headache disorders. Neuropharmacology 2019; 148(77-86 Doi:10.1016/j.neuropharm.2018.12.017 DOI: https://doi.org/10.1016/j.neuropharm.2018.12.017
Mares C, Dagher JH and Harissi-Dagher M. Narrative Review of the Pathophysiology of Headaches and Photosensitivity in Mild Traumatic Brain Injury and Concussion. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 2018; 46(1): 14-22 Doi:10.1017/cjn.2018.361 DOI: https://doi.org/10.1017/cjn.2018.361
Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, . . . Brin MF. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 2010; 30(7): 804-814 Doi:10.1177/0333102410364677 DOI: https://doi.org/10.1177/0333102410364677
Kumar R. Therapeutic use of botulinum toxin in pain treatment. Neuronal Signaling 2018; 2(3): Doi:10.1042/ns20180058 DOI: https://doi.org/10.1042/NS20180058
Wissel J, Müller J, Dressnandt J, Heinen F, Naumann M, Topka H and Poewe W. Management of Spasticity Associated Pain with Botulinum Toxin A. Journal of Pain and Symptom Management 2000; 20(1): 44-49 Doi:10.1016/s0885-3924(00)00146-9 DOI: https://doi.org/10.1016/S0885-3924(00)00146-9
Snow BJ, Tsui JKC, Bhatt MH, Varelas M, Hashimoto SA and Calne DB. Treatment of spasticity with botulinum toxin: A double-blind study. Annals of Neurology 1990; 28(4): 512-515 Doi:10.1002/ana.410280407 DOI: https://doi.org/10.1002/ana.410280407
Tsui JC, Jon Stoessl A, Eisen A, Calne S and Calne D. Double-Blind Study of Botulinum Toxin in Spasmodic Torticollis. The Lancet 1986; 328(8501): 245-247 Doi:10.1016/s0140-6736(86)92070-2 DOI: https://doi.org/10.1016/S0140-6736(86)92070-2
Matak, Bölcskei, Bach R and Helyes. Mechanisms of Botulinum Toxin Type A Action on Pain. Toxins 2019; 11(8): Doi:10.3390/toxins11080459 DOI: https://doi.org/10.3390/toxins11080459
Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF, Bock SA, Branum A, . . . Decker WW. Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Journal of Allergy and Clinical Immunology 2006; 117(2): 391-397 Doi:10.1016/j.jaci.2005.12.1303 DOI: https://doi.org/10.1016/j.jaci.2005.12.1303
Rodrigues FB, Duarte GS, Marques RE, Castelão M, Ferreira J, Sampaio C, . . . Costa J. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database of Systematic Reviews 2020; 2020(11): Doi:10.1002/14651858.CD003633.pub4 DOI: https://doi.org/10.1002/14651858.CD003633.pub4
Aggarwal A, Kaul V, Kaur G, Banas E, Sampath P and Roy AK. A new facial expression to botox! The American Journal of Emergency Medicine 2014; 32(3): 290.e295-290.e296 Doi:10.1016/j.ajem.2013.10.017 DOI: https://doi.org/10.1016/j.ajem.2013.10.017
Moon IJ, Chang SE and Kim SD. First case of anaphylaxis after botulinum toxin type A injection. Clinical and Experimental Dermatology 2017; 42(7): 760-762 Doi:10.1111/ced.13108 DOI: https://doi.org/10.1111/ced.13108
Careta MF, Delgado L and Patriota R. Report of Allergic Reaction After Application of Botulinum Toxin. Aesthetic Surgery Journal 2015; 35(5): NP102-NP105 Doi:10.1093/asj/sju105 DOI: https://doi.org/10.1093/asj/sju105
Li M, Goldberger BA and Hopkins C. Fatal case of BOTOX-related anaphylaxis? J Forensic Sci 2005; 50(1): 169-172 DOI: https://doi.org/10.1520/JFS2004196
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2023 Joe Ghorayeb, Timithy McClellan, Kelley Crozier (Author)
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
